tetravalent shigella vaccine candidate S4V2 — Interim data
H2 2026
o A decision on subsequent development steps is anticipated in the second half of 2026Source filing
VALN biotech catalysts & pipeline
VALNEVA SE · Data as of 2026-10-25
catalyst calendar
/